Skip to content
Subscriber Only

EU, Sanofi Talks on Covid-19 Vaccine Aim for Supply Next Year

  • Deal would be for 300 million doses in second half of 2021
  • Talks are part of broad EU outreach campaign to drug companies
Photographer: Anthony Kwan/Bloomberg

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

European Union negotiations with Sanofi to secure a coronavirus vaccine aim for 300 million doses in the second half of 2021, according to a person familiar with the situation.